New experimental approach may help overcome drug resistance in deadly brain cancer

Дата публикации: 09-07-2026 16:20:05

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive forms of brain cancer: resistance to chemotherapy. The study shows that an experimental compound called BA-101 can restore the effectiveness of the standard drug temozolomide (TMZ) by blocking a biological process known as nitrosative stress, which helps tumors survive and resist treatment.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients	7	8	10-07-2026
2	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
3	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
4	Cancer evolution study reveals biology of glioma progression	2	7	10-07-2026
5	Получено перспективное соединение для создания нового препарата против рака	0	0	24-02-2025
6	Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors	2	8	20-07-2026
7	The AECC supports a dozen CNIO projects to improve immunotherapy and chemotherapy, advance prevention, and treat early-stage brain metastasis	0	12.32	26-06-2026
8	Российские ученые разрабатывают имплантант для борьбы с раком мозга	0	0	21-08-2019
9	В ФМБА завершили доклиническое исследование нового противоопухолевого препарата	0	0	04-03-2025
10	Tiny BAP1 mutations can disrupt internal signals that suppress tumor growth	0	12.72	24-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 8. Источник: medicalxpress.com.